LTBP-2 Has a Single High-Affinity Binding Site for FGF-2 and Blocks FGF-2-Induced Cell Proliferation

Latent transforming growth factor-beta-1 binding protein-2 (LTBP-2) belongs to the fibrillin-LTBP superfamily of extracellular matrix proteins. LTBPs and fibrillins are involved in the sequestration and storage of latent growth factors, particularly transforming growth factor β (TGF-β), in tissues. Unlike other LTBPs, LTBP-2 does not covalently bind TGF-β, and its molecular functions remain unclear. We are screening LTBP-2 for binding to other growth factors and have found very strong saturable binding to fibroblast growth factor-2 (FGF-2) (Kd = 1.1 nM). Using a series of recombinant LTBP-2 fragments a single binding site for FGF-2 was identified in a central region of LTBP-2 consisting of six tandem epidermal growth factor-like (EGF-like) motifs (EGFs 9–14). This region was also shown to contain a heparin/heparan sulphate-binding site. FGF-2 stimulation of fibroblast proliferation was completely negated by the addition of 5-fold molar excess of LTBP-2 to the assay. Confocal microscopy showed strong co-localisation of LTBP-2 and FGF-2 in fibrotic keloid tissue suggesting that the two proteins may interact in vivo. Overall the study indicates that LTBP-2 is a potent inhibitor of FGF-2 that may influence FGF-2 bioactivity during wound repair particularly in fibrotic tissues.

[1]  K. Kameyama,et al.  Latent TGF-β binding protein-2 is essential for the development of ciliary zonule microfibrils. , 2014, Human molecular genetics.

[2]  C. Shu,et al.  Confocal microscopy demonstrates association of LTBP-2 in fibrillin-1 microfibrils and colocalisation with perlecan in the disc cell pericellular matrix. , 2014, Tissue & cell.

[3]  M. Sideek,et al.  LTBP-2 competes with tropoelastin for binding to fibulin-5 and heparin, and is a negative modulator of elastinogenesis. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[4]  R. Knutsen,et al.  Microfibril-associated Glycoprotein 2 (MAGP2) Loss of Function Has Pleiotropic Effects in Vivo* , 2013, The Journal of Biological Chemistry.

[5]  S. Bellusci,et al.  The Anti-Scar Effects of Basic Fibroblast Growth Factor on the Wound Repair In Vitro and In Vivo , 2013, PloS one.

[6]  D. Zillikens,et al.  Topically applied flightless I neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisita. , 2013, The Journal of investigative dermatology.

[7]  M. Mohammadi,et al.  Exploring mechanisms of FGF signalling through the lens of structural biology , 2013, Nature Reviews Molecular Cell Biology.

[8]  D. Rifkin,et al.  Specificity of latent TGF‐β binding protein (LTBP) incorporation into matrix: Role of fibrillins and fibronectin , 2012, Journal of cellular physiology.

[9]  C. Baldock,et al.  Fibrillin-1 Mutations Causing Weill-Marchesani Syndrome and Acromicric and Geleophysic Dysplasias Disrupt Heparan Sulfate Interactions , 2012, PloS one.

[10]  A. Mebazaa,et al.  The novel marker LTBP2 predicts all-cause and pulmonary death in patients with acute dyspnoea. , 2012, Clinical science.

[11]  D. Reinhardt,et al.  Immobilized Metal Affinity Chromatography Co-Purifies TGF-β1 with Histidine-Tagged Recombinant Extracellular Proteins , 2012, PloS one.

[12]  Juan F. García,et al.  Genetic Alterations Associated With Progression and Recurrence in Meningiomas , 2012, Journal of neuropathology and experimental neurology.

[13]  Seyed Hassan Paylakhi,et al.  LTBP2 mutations cause Weill–Marchesani and Weill–Marchesani‐like syndrome and affect disruptions in the extracellular matrix , 2012, Human mutation.

[14]  H. Dietz,et al.  Matrix‐dependent perturbation of TGFβ signaling and disease , 2012, FEBS letters.

[15]  A. Bayat,et al.  Extracellular matrix molecules implicated in hypertrophic and keloid scarring , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[16]  Y. Tabata,et al.  Therapeutic potential of fibroblast growth factor-2 for hypertrophic scars: upregulation of MMP-1 and HGF expression , 2012, Laboratory Investigation.

[17]  J. Melrose,et al.  Comparative Immunolocalization of the Elastin Fiber–Associated Proteins Fibrillin-1, LTBP-2, and MAGP-1 With Components of the Collagenous and Proteoglycan Matrix of the Fetal Human Intervertebral Disc , 2011, Spine.

[18]  S. Law,et al.  The ECM protein LTBP‐2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome , 2011, International journal of cancer.

[19]  Takako Sasaki,et al.  Prodomains of transforming growth factor beta (TGFbeta) superfamily members specify different functions: extracellular matrix interactions and growth factor bioavailability. , 2011, The Journal of biological chemistry.

[20]  Justin S. Weinbaum,et al.  The matrix-binding domain of microfibril-associated glycoprotein-1 targets active connective tissue growth factor to a fibroblast-produced extracellular matrix. , 2010, Macromolecular bioscience.

[21]  S. Blanton,et al.  A homozygous mutation in LTBP2 causes isolated microspherophakia , 2010, Human Genetics.

[22]  D. Keene,et al.  In Vivo Studies of Mutant Fibrillin-1 Microfibrils* , 2010, The Journal of Biological Chemistry.

[23]  J. Adams,et al.  LTBP-2 has multiple heparin/heparan sulfate binding sites. , 2010, Matrix biology : journal of the International Society for Matrix Biology.

[24]  M. Abramowicz,et al.  LTBP2 null mutations in an autosomal recessive ocular syndrome with megalocornea, spherophakia, and secondary glaucoma , 2010, European Journal of Human Genetics.

[25]  N. Turner,et al.  Fibroblast growth factor signalling: from development to cancer , 2010, Nature Reviews Cancer.

[26]  J. Keski‐Oja,et al.  Matrix association of latent TGF‐beta binding protein‐2 (LTBP‐2) is dependent on fibrillin‐1 , 2009, Journal of cellular physiology.

[27]  Seyed Hassan Paylakhi,et al.  Loss of function mutations in the gene encoding latent transforming growth factor beta binding protein 2, LTBP2, cause primary congenital glaucoma. , 2009, Human molecular genetics.

[28]  D. Rifkin,et al.  Extracellular microfibrils: contextual platforms for TGFbeta and BMP signaling. , 2009, Current opinion in cell biology.

[29]  D. Mackey,et al.  Null mutations in LTBP2 cause primary congenital glaucoma. , 2009, American journal of human genetics.

[30]  G. Schultz,et al.  Interactions between extracellular matrix and growth factors in wound healing , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[31]  Justin S. Weinbaum,et al.  Deficiency in Microfibril-associated Glycoprotein-1 Leads to Complex Phenotypes in Multiple Organ Systems* , 2008, Journal of Biological Chemistry.

[32]  Olivera Stojadinovic,et al.  PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[33]  M. Roger,et al.  Evidence for a major role of endogenous fibroblast growth factor‐2 in apoptotic cortex‐induced subventricular zone cell proliferation , 2007, The European journal of neuroscience.

[34]  E. Maltezos,et al.  Angiogenic growth factors in the treatment of peripheral arterial disease. , 2007, Current vascular pharmacology.

[35]  D. Ribatti,et al.  The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies. , 2007, Cytokine & growth factor reviews.

[36]  E. Kardami,et al.  Fibroblast growth factor-2 and cardioprotection , 2007, Heart Failure Reviews.

[37]  E. Hanssen,et al.  LTBP-2 specifically interacts with the amino-terminal region of fibrillin-1 and competes with LTBP-1 for binding to this microfibrillar protein. , 2007, Matrix biology : journal of the International Society for Matrix Biology.

[38]  D. Brann,et al.  Induction of transforming growth factor‐β1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP‐1 activation , 2007, Journal of neuroscience research.

[39]  A. Galloway,et al.  Basic fibroblast growth factor (FGF‐2): The high molecular weight forms come of age , 2007, Journal of cellular biochemistry.

[40]  C. Kielty,et al.  Elastic fibres in health and disease , 2006, Expert Reviews in Molecular Medicine.

[41]  D. Rifkin.  Latent Transforming Growth Factor-β (TGF-β) Binding Proteins: Orchestrators of TGF-β Availability* , 2005, Journal of Biological Chemistry.

[42]  E. Hanssen,et al.  MAGP-2 Has Multiple Binding Regions on Fibrillins and Has Covalent Periodic Association with Fibrillin-containing Microfibrils* , 2004, Journal of Biological Chemistry.

[43]  D. Rifkin,et al.  Integrin αVβ6-mediated activation of latent TGF-β requires the latent TGF-β binding protein-1 , 2004, The Journal of cell biology.

[44]  A. Desmoulière,et al.  Fibrillin‐1 and elastin are differentially expressed in hypertrophic scars and keloids , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[45]  Kimberly Forsten-Williams,et al.  Heparan Sulfate Proteoglycans Function as Receptors for Fibroblast Growth Factor-2 Activation of Extracellular Signal–Regulated Kinases 1 and 2 , 2004, Circulation research.

[46]  J. Keski‐Oja,et al.  Latent TGF-β Binding Proteins: Extracellular Matrix Association and Roles in TGF-β Activation , 2004 .

[47]  D. Rifkin,et al.  Latent Transforming Growth Factor β-binding Protein 1 Interacts with Fibrillin and Is a Microfibril-associated Protein* , 2003, The Journal of Biological Chemistry.

[48]  A. Munnich,et al.  In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome , 2003, Journal of medical genetics.

[49]  A. Heagerty,et al.  Expression of latent TGF-beta binding proteins and association with TGF-beta 1 and fibrillin-1 following arterial injury. , 2002, Cardiovascular research.

[50]  Juha Saharinen,et al.  Specific Sequence Motif of 8-Cys Repeats of TGF-β Binding Proteins, LTBPs, Creates a Hydrophobic Interaction Surface for Binding of Small Latent TGF-β , 2000 .

[51]  Jeffrey Bonadio,et al.  Developmental Expression of Latent Transforming Growth Factor β Binding Protein 2 and Its Requirement Early in Mouse Development , 2000, Molecular and Cellular Biology.

[52]  M. Gibson,et al.  Microfibril-associated Glycoprotein-1 (MAGP-1) Binds to the Pepsin-resistant Domain of the α3(VI) Chain of Type VI Collagen* , 1997, The Journal of Biological Chemistry.

[53]  A. Phillips,et al.  Basic fibroblast growth factor stimulates the release of preformed transforming growth factor beta 1 from human proximal tubular cells in the absence of de novo gene transcription or mRNA translation. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[54]  G. Sutherland,et al.  Bovine latent transforming growth factor beta 1-binding protein 2: molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils , 1995, Molecular and cellular biology.

[55]  Hans C. Korting,et al.  Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies , 2011, Molecular medicine.

[56]  H. Kim,et al.  Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration , 2010 .

[57]  L. Sakai,et al.  Biogenesis and function of fibrillin assemblies , 2009, Cell and Tissue Research.

[58]  D. Rifkin.  Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability. , 2005, The Journal of biological chemistry.

[59]  C. Baldock,et al.  Fibrillin microfibrils. , 2005, Advances in protein chemistry.

[60]  J. Keski‐Oja,et al.  Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. , 2004, Critical reviews in clinical laboratory sciences.

[61]  J. Keski‐Oja,et al.  Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta. , 2000, Molecular biology of the cell.